+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase (Retail, Non-Retail) - Global Forecast to 2026

  • ID: 5354125
  • Report
  • June 2021
  • Region: Global
  • 217 Pages
  • Markets and Markets
The Pen Needles Market is Expected to Reach USD 2.2 Billion by 2026 from An Estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%

FEATURED COMPANIES

  • Advacare Pharma
  • Artsana Group
  • Glucorx
  • Links Medical Products
  • Nipro Corporation
  • Promisemed Diabetes Care
  • MORE

The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug delivery, poor reimbursement in developing countries, and needle anxiety are expected to restrain the overall market growth. The growing preference for biosimilar drugs and emerging markets are areas of opportunity in the market. The challenges faced by the market are reuse of pen needles and misuse of injection pens.

Based on product type, the standard pen needles segment holds the largest market share during the forecast period. 

Based on type, the pen needles market is segmented into standard and safety pen needles. In 2020, the standard pen needles segment accounted for the largest share in the pen needles market. Standard pen needles are preferred over safety pen needles as they are more affordable, especially considering the need for daily insulin intake. The low cost of standard pen needles has also led to their wide adoption in emerging economies such as China, India, and Brazil, where the use of safety pen needles is low to negligible.

Based on length, the 8mm segment grows at the highest market share during the forecast period. 

Based on length, the market is segmented into 4mm (5/32’’), 5mm (3/16’’), 6mm (1/4’’), 8mm (5/16’’), 10mm, and 12mm (1/2’’). In 2020, the 8mm segment accounted for the largest share in the pen needles market. The large share of this segment is mainly attributed to the wide adoption of these needles among diabetes patients. 

Based on mode of purchase, the retail segment is expected to register the highest CAGR during the forecast period. 

Based on the mode of purchase, the market is categorized into retail and non-retail. The retail segment accounted for the largest share and highest growth during the forecast period. The significant discounts offered on online/retail purchases of pen needles, high convenience, increasing awareness on pen needles, and the favorable reimbursement scenario in North America and Europe are some of the key factors driving the growth of the retail segment.

Based on therapy, the insulin therapy segment is expected to register the highest CAGR during the forecast period. 

Based on therapy, the market is categorized into insulin therapy, glucagon-like peptide-1 (GLP-1) therapy, growth hormone therapy, and other therapies (osteoporosis, thyroid, obesity). In 2020, insulin therapy held maximum of the global pen needles market, primarily due to the high and growing diabetic population globally. This segment is also expected to grow at the highest rate during the forecast period.

North America is expected to account for the largest share of the pen needles market in 2020 

Geographically, the pen needles market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the pen needles market in 2020. The growing diabetes prevalence and favorable reimbursement scenario for pen needles, federal initiatives to create awareness about injection techniques, increasing market penetration by leading players, and the development of improved pen needle technologies are driving market growth in the US.

Breakdown of primary participants was as mentioned below:

  • By Company Type - Tier 1-60%, Tier 2-30%, and Tier 3-10%
  • By Designation - C-level-30%, Director-level-50%, Others-20%
  • By Region - North America-45%, Europe-15%, Asia Pacific-25%, Latin America- 10%, Middle East and Africa-5%

Key players in the Pen Needles Market

The key players in the pen needles market include Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), Owen Mumford (UK), Terumo Corporation (Japan), Nipro Corporation (Japan) Allison Medical (US), AdvaCare Pharma (US), Berpu Medical Technology (China), ARKRAY (Japan), GlucoRx (UK), HTL-STREFA (Poland), UltiMed, (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), PromiseMed Diabetes Care (Canada), Montmed (Canada), Trividia Health (US), VOGT Medical Vertrieb (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), Iyon (Turkey), Links Medical Products (US), and MHC Medical Products (US).

Research Coverage:

The report analyzes the pen needles market and aims at estimating the market size and future growth potential of this market based on various segments such as type, length, therapy, mode of purchase, and region. The report also includes a product portfolio matrix of various pen needles available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies. 

Reasons to Buy the Report 

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global pen needles market. The report analyzes this market by type, therapy, length, and mode of purchase
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global pen needles market
  • Market Development: Comprehensive information on the lucrative emerging markets by type, therapy, length, and mode of purchase
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global pen needles market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global pen needles market. 
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Advacare Pharma
  • Artsana Group
  • Glucorx
  • Links Medical Products
  • Nipro Corporation
  • Promisemed Diabetes Care
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions of the Study
1.2.2 Market Segmentation
1.2.3 Years Considered for the Study
1.3 Currency
1.3.1 Exchange Rates Utilized for the Conversion to Usd
1.4 Limitations
1.5 Stakeholders
1.6 Summary of Changes

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
Figure 2 Primary Sources
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 4 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants (Pen Needles Market)
2.2 Market Size Estimation
Figure 5 Supply-Side Market Size Estimation: Revenue Share Analysis
Figure 6 Revenue Share Analysis Illustration: Becton, Dickinson and Company (2020)
Figure 7 Revenue Analysis of the Top Five Companies: Pen Needles Market (2020)
Figure 8 Demand-Side Analysis
Figure 9 CAGR Projections: Supply-Side Analysis
Figure 10 CAGR Projections from the Analysis of Drivers, Restraints, Opportunities, and Challenges of the Pen Needles Market (2021-2026)
Figure 11 Top-Down Approach
2.3 Market Breakdown & Data Triangulation
Figure 12 Market Data Triangulation Methodology
2.4 Market Share Analysis
2.5 Assumptions for the Study
2.6 Risk Assessment
Table 1 Risk Assessment: Pen Needles Market

3 Executive Summary
Figure 13 Pen Needles Market, by Type, 2021 Vs. 2026 (USD Million)
Figure 14 Pen Needles Market, by Length, 2021 Vs. 2026 (USD Million)
Figure 15 Pen Needles Market, by Therapy, 2021 Vs. 2026 (USD Million)
Figure 16 Pen Needles Market, by Mode of Purchase, 2021 Vs. 2026 (USD Million)
Figure 17 Geographic Snapshot: Pen Needles Market

4 Premium Insights
4.1 Pen Needles Market Overview
Figure 18 Growing Prevalence of Chronic Diseases to Drive the Growth of the Pen Needles Market
4.2 Asia-Pacific: Pen Needles Market, by Therapy and Country
Figure 19 Japan Dominates the APAC Market
4.3 Pen Needles Market: Geographic Mix
Figure 20 India & China to Witness the Highest Growth in the Pen Needles Market During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 21 Pen Needles Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Chronic Diseases
Figure 22 Number of People with Chronic Conditions in the Us, 1995-2030 (Million Individuals)
Figure 23 Estimated Diabetic Population, by Region, 2019 Vs. 2030 Vs. 2040
5.2.1.2 Favorable Reimbursement in Select Countries
5.2.2 Restraints
5.2.2.1 Preference for Alternative Modes of Drug Delivery
5.2.2.2 Poor Reimbursement Scenario in Developing Countries
5.2.2.3 Needle Anxiety
5.2.3 Opportunities
5.2.3.1 Growing Preference for Biosimilar Drugs
5.2.3.2 Emerging Markets
Table 2 Rising Income Levels in Emerging Countries
5.2.4 Challenges
5.2.4.1 Reuse of Pen Needles
5.2.4.2 Misuse of Injection Pens
5.3 Pricing Analysis
Table 3 Pricing of Pen Needles Available in the Market
5.4 Value Chain Analysis
Figure 24 Pen Needles Market: Value Chain Analysis
5.5 Ecosystem Market Map
Figure 25 Pen Needles Market: Ecosystem Market Map
5.6 Porter's Five Forces Analysis
Table 4 Pen Needles Market: Porter's Five Forces Analysis
5.6.1 Intensity of Competitive Rivalry
5.6.2 Bargaining Power of Suppliers
5.6.3 Bargaining Power of Buyers
5.6.4 Threat of Substitutes
5.6.5 Threat of New Entrants
5.7 Supply Chain Analysis
Figure 26 Pen Needles Market: Supply Chain Analysis
5.8 Regulatory Analysis
5.8.1 North America
5.8.1.1 US
Table 5 Us Fda: Medical Device Classification
Table 6 US: Medical Device Regulatory Approval Process
5.8.1.2 Canada
Table 7 Canada: Medical Device Regulatory Approval Process
Figure 27 Canada: Class Ii Medical Device Approval Process
5.8.2 Europe
Figure 28 Europe: Ce Approval Process for Class Iia Medical Devices
5.8.3 Asia-Pacific
5.8.3.1 Japan
Table 8 Japan: Medical Device Classification Under Pmda
5.8.3.2 China
Table 9 China: Regulatory Bodies Appointed for Medical Device Approval
Table 10 China: Classification of Medical Devices
5.8.3.3 India
5.9 Impact of COVID-19 on the Pen Needles Market
5.10 Patent Analysis
5.10.1 Patent Publication Trends for Pen Needles
Figure 29 Patent Publication Trends (2011-May 2021)
5.10.2 Insights: Jurisdiction and Top Applicant Analysis
Figure 30 Top Applicants & Owners (Companies/Institutions) for Pen Needles Patents (January 2011-June 2021)
Figure 31 Top Applicant Countries/Regions for Pen Needle Patents (January 2011-June 2021)
5.11 Technology Analysis
5.11.1 Key Technology
5.11.1.1 Fluid Flow Enhancement Technology
5.11.2 Complementary Technology
5.11.2.1 Microfabricated Needles
5.11.3 Adjacent Technology
5.11.3.1 Autoinjectors

6 Pen Needles Market, by Type
6.1 Introduction
Table 11 Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 12 Pen Needles Market, by Type, 2019-2026 (Million Units)
6.2 Standard Pen Needles
6.2.1 Standard Pen Needles are Preferred Over Safety Pen Needles as They are More Affordable
Table 13 Standard Pen Needles Offered by Key Players
Table 14 Standard Pen Needles Market, by Country, 2019-2026 (USD Million)
Table 15 Standard Pen Needles Market, by Country, 2019-2026 (Million Units)
6.3 Safety Pen Needles
6.3.1 Growing Concern Over Needlestick Injuries Drives the Growth of Safety Pen Needles
Table 16 Safety Pen Needles Offered by Key Players
Table 17 Safety Pen Needles Market, by Country, 2019-2026 (USD Million)
Table 18 Safety Pen Needles Market, by Country, 2019-2026 (Million Units)

7 Pen Needles Market, by Length
7.1 Introduction
Table 19 Pen Needles Market, by Length, 2019-2026 (USD Million)
7.2 8Mm
7.2.1 8Mm Pen Needles Will Continue to Dominate the Pen Needles Market During the Forecast Period
Table 20 8Mm Pen Needles Offered by Key Players
Table 21 8Mm Pen Needles Market, by Country, 2019-2026 (USD Million)
7.3 5Mm
7.3.1 5Mm Pen Needles to Register Second-Highest Growth Rate During the Study Period
Table 22 5Mm Pen Needles Offered by Key Players
Table 23 5Mm Pen Needles Market, by Country, 2019-2026 (USD Million)
7.4 6Mm
7.4.1 6Mm Pen Needles are the Most Commonly Used Needles Across the Globe
Table 24 6Mm Pen Needles Offered by Key Players
Table 25 6Mm Pen Needles Market, by Country, 2019-2026 (USD Million)
7.5 4Mm
7.5.1 4Mm Pen Needles are Expected to Register the Highest Growth Rate During the Forecast Period
Table 26 4Mm Pen Needles Offered by Key Players
Table 27 4Mm Pen Needles Market, by Country, 2019-2026 (USD Million)
7.6 12Mm
7.6.1 The Popularity of Shorter & Less Painful Needles Hampers the Growth of the 12Mm Pen Needles Market
Table 28 12Mm Pen Needles Offered by Key Players
Table 29 12Mm Pen Needles Market, by Country, 2019-2026 (USD Million)
7.7 10Mm
7.7.1 Availability of Shorter Pen Needles to Restrain the Growth of the 10Mm Pen Needles Market
Table 30 10Mm Pen Needles Offered by Key Players
Table 31 10Mm Pen Needles Market, by Country, 2019-2026 (USD Million)

8 Pen Needles Market, by Therapy
8.1 Introduction
Table 32 Pen Needles Market, by Therapy, 2019-2026 (USD Million)
8.2 Insulin Therapy
8.2.1 Rising Prevalence of Diabetes Drives the Growth of the Pen Needles Market for Insulin Therapy
Table 33 Pen Needles Market for Insulin Therapy, by Country, 2019-2026 (USD Million)
8.3 Glucagon-Like Peptide-1 Therapy
8.3.1 Strong Focus of Major Pharmaceutical Companies to Introduce Glp-1 Drugs to Drive Market Growth
Table 34 Pen Needles Market for Glp-1 Therapy, by Country, 2019-2026 (USD Million)
8.4 Growth Hormone Therapy
8.4.1 Development of Sustained-Release Growth Hormone Formulations for Reducing Injection Frequency to Restrain the Growth of the Pen Needles Market for Growth Hormone Therapy
Table 35 Pen Needles Market for Growth Hormone Therapy, by Country, 2019-2026 (USD Million)
8.5 Other Therapies
Table 36 Pen Needles Market for Other Therapies, by Country, 2019-2026 (USD Million)

9 Pen Needles Market, by Mode of Purchase
9.1 Introduction
Table 37 Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
9.2 Retail
9.2.1 Retail Purchases of Pen Needles to Witness High Growth in the Coming Years Owing to the Growing Popularity of Online Purchases
Table 38 Pen Needles Market for Retail Purchases, by Country, 2019-2026 (USD Million)
9.3 Non-Retail
9.3.1 Large Number of Needle-Phobic Diabetic Patients is Supporting the Growth of this Segment
Table 39 Indicative List of Regulations
Table 40 Pen Needles Market for Non-Retail Purchases, by Country, 2019-2026 (USD Million)

10 Pen Needles Market, by Region
10.1 Introduction
Table 41 Pen Needles Market, by Region, 2019-2026 (USD Million)
Figure 32 Emerging Countries are Expected to Witness Higher Growth Over the Forecast Period
10.2 North America
Figure 33 North America: Pen Needles Market Snapshot
Table 42 North America: Pen Needles Market, by Country, 2019-2026 (USD Million)
Table 43 North America: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 44 North America: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 45 North America: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 46 North America: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.2.1 US
10.2.1.1 The Us Dominates the Global Pen Needles Market
Figure 34 Total Fertility Rate in the Us Population (1990-2020)
Table 47 US: Key Macroindicators
Table 48 US: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 49 US: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 50 US: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 51 US: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.2.2 Canada
10.2.2.1 Unfavorable Regulatory Processes in Canada to Restrain the Market Growth
Table 52 Canada: Key Macroindicators
Table 53 Canada: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 54 Canada: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 55 Canada: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 56 Canada: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.3 Europe
Table 57 Europe: Pen Needles Market, by Country, 2019-2026 (USD Million)
Table 58 Europe: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 59 Europe: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 60 Europe: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 61 Europe: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.3.1 Germany
10.3.1.1 High Diabetes Expenditure and Reimbursement for Pen Needles is Expected to Drive the Market in Germany
Table 62 Germany: Key Macroindicators
Table 63 Germany: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 64 Germany: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 65 Germany: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 66 Germany: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.3.2 France
10.3.2.1 Favorable Health Insurance System to Drive the Pen Needles Market in France
Table 67 France: Key Macroindicators
Table 68 France: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 69 France: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 70 France: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 71 France: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million) 2019-2026 (USD Million) 120 
10.3.3 UK
10.3.3.1 Nhs Support and Access to Cost-Effective Pen Needles are Likely to Drive the Market in the UK
Table 72 UK: Key Macroindicators
Table 73 UK: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 74 UK: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 75 UK: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 76 UK: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.3.4 Italy
10.3.4.1 Regional Variation in Terms of Coverage and Benefits to Hinder the Market Growth
Table 77 Italy: Key Macroindicators
Table 78 Italy: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 79 Italy: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 80 Italy: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 81 Italy: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.3.5 Spain
10.3.5.1 Supportive Regulations Mandating the Use of Safety Pen Needles to Boost the Growth of the Spanish Market
Table 82 Spain: Key Macroindicators
Table 83 Spain: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 84 Spain: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 85 Spain: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 86 Spain: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.3.6 Rest of Europe
Table 87 Roe: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 88 Roe: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 89 Roe: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 90 Roe: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.4 Asia-Pacific
Figure 35 APAC: Pen Needles Market Snapshot
Table 91 APAC: Pen Needles Market, by Country, 2019-2026 (USD Million)
Table 92 APAC: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 93 APAC: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 94 APAC: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 95 APAC: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.4.1 Japan
10.4.1.1 High Diabetes Incidence and Supportive Reimbursement Policies to Drive the Market Growth in Japan
Table 96 Japan: Key Macroindicators
Table 97 Japan: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 98 Japan: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 99 Japan: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 100 Japan: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.4.2 China
10.4.2.1 Large Patient Population and Healthcare Infrastructure Improvements to Drive the Market Growth in China
Table 101 China: Key Macroindicators
Table 102 China: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 103 China: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 104 China: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 105 China: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.4.3 Australia and New Zealand
10.4.3.1 Growing Geriatric Population in Australia and New Zealand to Drive the Pen Needles Market
Table 106 Australia and New Zealand: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 107 Australia and New Zealand: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 108 Australia and New Zealand: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 109 Australia and New Zealand: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.4.4 India
10.4.4.1 Healthcare Infrastructural Improvements and Implementation of Favorable Government Initiatives Support the Market in India
Table 110 India: Key Macroindicators
Table 111 India: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 112 India: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 113 India: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 114 India: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.4.5 South Korea
10.4.5.1 Growing Chronic Diseases in the Geriatric Population Augments the Growth of the Pen Needles Market
Table 115 South Korea: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 116 South Korea: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 117 South Korea: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 118 South Korea: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.4.6 Southeast Asia
10.4.6.1 Growing Awareness About Diabetes Drives the Pen Needles Market
Figure 36 Growing Prevalence of Diabetes in Southeast Asia
Figure 37 Healthcare Expenditure (% Gdp) in Southeast Asia (2018)
Figure 38 Geriatric Population in 2019 (% of Total Population)
Table 119 Southeast Asia: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 120 Southeast Asia: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 121 Southeast Asia: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 122 Southeast Asia: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.4.7 Rest of APAC
Table 123 Roapac: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 124 Roapac: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 125 Roapac: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 126 Roapac: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.5 Latin America
Table 127 Latin America: Pen Needles Market, by Country, 2019-2026 (USD Million)
Table 128 Latin America: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 129 Latin America: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 130 Latin America: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 131 Latin America: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.5.1 Brazil
10.5.1.1 Brazil Dominates the Pen Needles Market in Latin America
Table 132 Brazil: Key Macroindicators
Table 133 Brazil: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 134 Brazil: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 135 Brazil: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 136 Brazil: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.5.2 Mexico
10.5.2.1 Increasing Incidence of Lifestyle-Related Disorders and Rising Awareness Drive Market Growth in Mexico
Table 137 Mexico: Key Macroindicators
Table 138 Mexico: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 139 Mexico: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 140 Mexico: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 141 Mexico: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.5.3 Rest of Latin America
Figure 39 Health Expenditure in Latin American Countries in 2018 (% Gdp)
Table 142 Rola: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 143 Rola: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 144 Rola: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 145 Rola: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)
10.6 Middle East and Africa
10.6.1 Initiatives to Enhance Healthcare Accessibility May Support Market Growth
Table 146 Mea: Pen Needles Market, by Type, 2019-2026 (USD Million)
Table 147 Mea: Pen Needles Market, by Length, 2019-2026 (USD Million)
Table 148 Mea: Pen Needles Market, by Therapy, 2019-2026 (USD Million)
Table 149 Mea: Pen Needles Market, by Mode of Purchase, 2019-2026 (USD Million)

11 Competitive Landscape
11.1 Overview
11.2 Key Player Strategies
11.3 Revenue Share Analysis of the Top Market Players
Figure 40 Revenue Analysis of the Top Players in the Pen Needles Market
11.4 Market Share Analysis
Figure 41 Pen Needles Market Share, by Key Player, 2020
11.5 Company Evaluation Quadrant
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
Figure 42 Pen Needles Market: Company Evaluation Quadrant (2020)
11.6 Company Evaluation Quadrant for Start-Ups
11.6.1 Progressive Companies
11.6.2 Dynamic Companies
11.6.3 Starting Blocks
11.6.4 Responsive Companies
Figure 43 Pen Needles Market: Company Evaluation Quadrant for Start-Ups (2020)
11.7 Company Product Footprint
Table 150 Product Portfolio Analysis: Pen Needles Market
Table 151 Product Portfolio Analysis: Pen Needles Market, by Length
Table 152 Product Portfolio Analysis: Pen Needles Market, by Therapy
11.8 Company Geographic Footprint
Table 153 Geographic Revenue Mix: Pen Needles Market (2020)
11.9 Competitive Intensity
11.9.1 Evaluation Parameters
Table 154 Evaluation Parameters & Scores
11.9.2 Scoring Methodology for Competitive Intensity
Figure 44 Scoring Methodology for Competitive Intensity
11.9.3 Competitive Intensity Score, by Company
11.9.3.1 Competitive Intensity Score for Bd
Table 155 Competitive Intensity for Bd
11.9.3.2 Competitive Intensity Score for Novo Nordisk
Table 156 Competitive Intensity for Novo Nordisk
11.9.3.3 Competitive Intensity Score for Ypsomed
Table 157 Competitive Intensity for Ypsomed
11.9.4 Competitive Intensity Mapping: Bd, Novo Nordisk, and Ypsomed
Figure 45 Comparisons of Competitive Intensity Scores: Bd, Novo Nordisk, and Ypsomed
Figure 46 Relative Positioning of Companies Based on Competitive Intensity Score and Pen Needle Focus
11.9.4.1 Product Launches/Technological Advancements
Figure 47 Bd Has a Higher Focus on Innovation for Its Pen Needles Business
11.9.4.2 Promotional/Marketing Activities
Figure 48 Bd and Novo Nordisk Showcase a High Focus on Marketing & Promotional Activities
11.9.4.3 Sponsorships/Donations/Education/Awareness Campaigns
Figure 49 Novo Nordisk A/S Has a High Focus on Diabetes Education & Awareness
11.9.4.4 Certifications/Accreditations/Awards
Figure 50 Bd, Novo Nordisk, and Ypsomed Equally Exhibit High Compliance with Industry Standards
11.1 Competitive Scenario
11.10.1 Product Launches
Table 158 Product Launches (January 2018 - June 2021)
11.10.2 Deals
Table 159 Deals (January 2018- June 2021)
11.10.3 Other Developments
Table 160 Other Developments (January 2018- June 2021)

12 Company Profiles
12.1 Key Players
(Business Overview, Products Offered, Recent Developments, Analyst's View)*
12.1.1 Becton, Dickinson and Company
Table 161 Becton, Dickinson and Company: Business Overview
Figure 51 Becton, Dickinson and Company: Company Snapshot (2020)
12.1.2 Novo Nordisk A/S
Table 162 Novo Nordisk A/S: Business Overview
Figure 52 Novo Nordisk A/S: Company Snapshot (2020)
12.1.3 Ypsomed Holding Ag
Table 163 Ypsomed Holding Ag: Business Overview
Figure 53 Ypsomed Holding Ag: Company Snapshot (2020)
12.1.4 B. Braun Melsungen Ag
Table 164 B. Braun Melsungen Ag: Business Overview
Figure 54 B. Braun Melsungen Ag: Company Snapshot (2020)
12.1.5 Terumo Corporation
Table 165 Terumo Corporation: Business Overview
Figure 55 Terumo Corporation: Company Snapshot (2020)
12.1.6 Nipro Corporation
Table 166 Nipro Corporation: Business Overview
Figure 56 Nipro Corporation: Company Snapshot (2020)
12.1.7 Owen Mumford
Table 167 Owen Mumford: Business Overview
12.1.8 Arkray
Table 168 Arkray: Business Overview
12.1.9 Ultimed
Table 169 Ultimed: Business Overview
12.1.10 Hindustan Syringes and Medical Devices
Table 170 Hindustan Syringes and Medical Devices: Business Overview
12.1.11 Montmed
Table 171 Montmed: Business Overview
12.1.12 Htl-Strefa
Table 172 Htl-Strefa: Business Overview
12.1.13 Allison Medical, Inc.
Table 173 Allison Medical: Business Overview
12.1.14 Glucorx
Table 174 Glucorx: Business Overview
12.1.15 Berpu Medical Technology
Table 175 Berpu Medical Technology: Business Overview
12.1.16 Advacare Pharma
Table 176 Advacare Pharma: Business Overview
12.1.17 Artsana Group
Table 177 Artsana Group: Business Overview
12.1.18 Promisemed Diabetes Care
Table 178 Promisemed Diabetes Care: Business Overview
12.1.19 Trividia Health
Table 179 Trividia Health: Business Overview
12.1.20 Vogt Medical Vertrieb
Table 180 Vogt Medical Vertrieb GmbH: Business Overview
*Business Overview, Products Offered, Recent Developments, Analyst's View Might Not be Captured in Case of Unlisted Companies.
12.2 Other Players
12.2.1 Van Heek Medical
Table 181 Van Heek Medical: Company Overview
12.2.2 Simple Diagnostics
Table 182 Simple Diagnostics: Company Overview
12.2.3 Iyon
Table 183 Iyon: Company Overview
12.2.4 Links Medical Products
Table 184 Links Medical Products: Company Overview
12.2.5 Mhc Medical Products
Table 185 Mhc Medical Products: Company Overview

13 Appendix
13.1 Discussion Guide

Note: Product cover images may vary from those shown
  • Advacare Pharma
  • Allison Medical, Inc.
  • Arkray
  • Artsana Group
  • B. Braun Melsungen Ag
  • Becton, Dickinson and Company
  • Berpu Medical Technology
  • Glucorx
  • Hindustan Syringes and Medical Devices
  • Htl-Strefa
  • Iyon
  • Links Medical Products
  • Mhc Medical Products
  • Montmed
  • Nipro Corporation
  • Novo Nordisk A/S
  • Owen Mumford
  • Promisemed Diabetes Care
  • Simple Diagnostics
  • Terumo Corporation
  • Trividia Health
  • Ultimed
  • Van Heek Medical
  • Vogt Medical Vertrieb
  • Ypsomed Holding Ag
Note: Product cover images may vary from those shown
Adroll
adroll